- Available:In stock1108
- Availability date:2020-07-30
- Dosage form:ampoules
- In stock:1108 Items
the drug has a non-specific stimulating and accelerating regeneration processes, as well as a softening and absorbing effect.
Pharmacokinetics Not studied.
Joint contractures of various origins, postoperative, burn, traumatic and other scars; to stimulate bone marrow formation; as an anesthetic for neuralgia, radiculitis, phantom pain; keratitis, ulcers, burns of the cornea (regression period), eye injuries.
The vitreous is administered subcutaneously and under the conjunctiva. adults daily s.c. 2 ml. the course of treatment for contractures, scars - up to 25 days, with neuralgia - 8-10 days. 0.3–0.5 ml are administered subconjunctively.
Infectious diseases, inflammatory processes, general exhaustion, nephritis, nephrosclerosis, cirrhosis of the liver, heart failure with edema, malignant tumors.
Allergic (urticaria, hyperemia of the skin) and anaphylactic reactions are possible. reactions in the form of pain and inflammation at the injection site are possible.
Use during pregnancy or lactation. not investigated.
Children. Application in children has not been investigated.
The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Not investigated.
At a temperature not exceeding 25 ° c.